%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%B4%D9%8A%D8%B1%D8%BA_%D8%B3%D8%AA%D8%B1%D8%A7%D9%88%D8%B3Category:Churg-Strauss_syndromeChurg%C5%AFv%E2%80%93Straussov%C3%A9_syndromEosinophile_Granulomatose_mit_PolyangiitisEosinophilic_granulomatosis_with_polyangiitisS%C3%ADndrome_de_Churg-Strauss%D8%B3%D9%86%D8%AF%D8%B1%D9%85_%DA%86%D8%B1%DA%AF_%D8%A7%D8%B4%D8%AA%D8%B1%D8%A7%D9%88%D8%B3Granulomatose_%C3%A9osinophilique_avec_polyang%C3%A9iteSiondr%C3%B3m_Churg-StraussS%C3%ADndrome_de_Churg-Strauss%D7%AA%D7%A1%D7%9E%D7%95%D7%A0%D7%AA_%D7%A6%27%D7%A8%D7%92_%D7%A9%D7%98%D7%A8%D7%90%D7%95%D7%A1%D4%B7%D5%B8%D5%A6%D5%AB%D5%B6%D5%B8%D6%86%D5%AB%D5%AC_%D5%A3%D6%80%D5%A1%D5%B6%D5%B8%D6%82%D5%AC%D5%A5%D5%B4%D5%A1%D5%BF%D5%B8%D5%A6_%D5%BA%D5%B8%D5%AC%D5%AB%D5%A1%D5%B6%D5%A3%D5%AB%D5%AB%D5%BF%D5%B8%D5%BESindrome_di_Churg-Strauss%E5%A5%BD%E9%85%B8%E7%90%83%E6%80%A7%E5%A4%9A%E7%99%BA%E8%A1%80%E7%AE%A1%E7%82%8E%E6%80%A7%E8%82%89%E8%8A%BD%E8%85%AB%E7%97%87%C4%8C%C4%93rd%C5%BEa%E2%80%94Strosas_sindromsSyndroom_van_Churg-StraussEosinofil_granulomatose_med_polyangiit_(EGPA)Zesp%C3%B3%C5%82_Churga-StraussS%C3%ADndrome_de_Churg-Strauss%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_CHARGE%D0%A7%D0%B0%D1%80%D0%B3-%D0%A8%D1%82%D1%80%D0%B0%D1%83%D1%81%D0%BE%D0%B2_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BCChurg%E2%80%93Strauss_syndromH%E1%BB%99i_ch%E1%BB%A9ng_Churg-StraussQ32811%E6%9F%A5%E6%A0%BC-%E6%96%BD%E7%89%B9%E5%8B%9E%E6%96%AF%E6%B0%8F%E7%97%87%E5%80%99%E7%BE%A4
about
Rituxan in Churg Strauss Syndrome With Renal InvolvementAmerican College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisLow Dose Naltrexone to Improve Physical Health in Patients With VasculitisOne-Time DNA Study for VasculitisNUCALA® Special Drug Use Investigation (EGPA, Long-term)Journey of Patients With Vasculitis From First Symptom to DiagnosisVasculitis Pregnancy RegistryClinical Transcriptomics in Systemic Vasculitis (CUTIS)A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisPediatric Vasculitis InitiativeVCRC Patient Contact Registry Patient-Reported Data Validation StudyEducational Needs of Patients With Systemic VasculitisVasculitis Illness Perception (VIP) StudyReproductive Health in Men and Women With VasculitisPRO Development for ANCA Associated VasculitisCyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesSafety and Efficacy Study of Mepolizumab in Churg Strauss SyndromeAssociation Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921The ANCA Vasculitis Questionnaire (AAV-PRO©)Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss SyndromeCHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis FactorsDetermining Disease Activity Biomarkers in Individuals With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsRATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing VasculitidesAnti-Interleukin-5 (IL-5) Study for Hypereosinophilic SyndromeMaintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesEosinophilic Granulomatosis With Polyangiitis CohortBenralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyVCRC Tissue RepositoryReslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyRituximab in Eosinophilic Granulomatosis With PolyangiitisImmuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss SyndromeA Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA)PRagmatic Analysis of Vitamin D in ANCA-Associated VasculitisHydroxychloroquine in ANCA Vasculitis Evaluation
P1050
P2175
Mepolizumab in eosinophilic disordersA case report and literature review of Churg-Strauss syndrome presenting with myocarditis.A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitisPatientHydroxychloroquine in ANCA Vasculitis Evaluation
P921
Q61921574-3CB2AB94-6D91-41D8-BE19-E1D3414D4193Q61939284-94A8C5FA-0C7C-43A1-ABC1-47D7EBEFFFF1Q62810428-62EAD550-6244-4E3E-A3A2-368EE916DF0FQ63340223-5B6A522E-8703-4C01-97FA-39298A41B637Q63397847-C47814BA-78BF-44EA-BF0D-B39FC6661E75Q63402938-45CAB3CC-4746-43A2-9C96-9B24394E3CB0Q64183710-03C7FE26-469C-42D8-9EFB-9632F1EA1555Q64189818-8ED7F5FA-4D1C-4AFD-BF9B-6C3DF8174DB5Q64350313-AB68A5A1-FB07-4089-B264-19187F220747Q64351519-9684EDC9-82B7-4352-8D4A-F4F18BA5EBC2Q64607539-A53CEF26-9783-470B-847B-62019F2502B0Q64607540-A631E29B-646C-47DB-9143-29E67E9C3E56Q64607541-3182E2EE-2124-4C42-A759-620C5502113EQ64611317-8676DB08-FCF1-4BE7-BCB9-67FCE1AD3BF5Q64638046-2F0C0487-0017-43E1-96F3-29F60BA54ED3Q64716581-9422DA84-FA52-439D-BBA3-CCE6D9B3B0ECQ64718479-15EFF306-038D-4B43-875E-4F01F65B2572Q64721207-6AD02A86-17E2-41B7-A100-54E4D2BBF0E1Q64790746-68B874DC-DE51-40BB-A6A4-35A000E34692Q65340207-212F6AA8-3376-4428-8852-24B1AD455054Q65381511-E0185BC8-CD58-4415-BF85-29F8CE977E8CQ65385857-771F5C45-E581-42A4-A3BE-CBE3AF420FC0Q65391157-F70561E5-2F53-466C-B8BF-4C16BED73226Q65474207-E4D2EC32-ADC1-4CDC-B5FD-ED837DBA5AB6Q65474222-BB9049FA-AA7D-4598-BDCC-1B8026C263EFQ65540964-7751B9F2-A18B-4A1A-A110-D3C04F9BF8EEQ66043964-F495CD3D-AD54-4694-80F9-36168B3A624AQ66060095-70D2C785-1161-4EFE-91CF-6C00E5D2F947Q66075326-65A68DE0-0942-47E1-A954-22F3B54C1DC8Q66075796-4A534B11-166E-4168-B3BF-9BFB6E7BA46DQ66078873-C77B2A11-A999-4250-AD10-EECB8108849EQ66079040-C33968BF-AC85-417F-AEE3-53A2CD39B90CQ66399957-737B97C5-779F-4B66-8D7F-0E321E9F6F28Q66547033-B9536489-486C-4D24-AC73-4C57DF9FCFDCQ76982658-4BA9A9CB-263E-45F9-9991-0D94D4F7D0C8Q87076196-46345B9F-B8D5-4E5B-BDF1-E722EAB1EAEEQ89154279-477A3BDD-498B-46CF-A210-97613E8D48DA
P1050
description
Eozynofilowa ziarniniakowatość z zapaleniem naczyń
@pl
Krankheit
@de
association d'asthme, hyperéos ...... autant veineuse qu'artérielle
@fr
malattia dei vasi sanguigni
@it
trastorno poco frecuente caracterizado por una inflamación de los vasos sanguíneos
@es
vasculitits that is systemic v ...... and gastrointestinal bleeding.
@en
name
Churg-Strauss syndrome
@en
Churg-Strauss-Syndrom
@de
Churg–Strauss syndrom
@sv
Eosinofil granulomatose med polyangiit
@nb
Hội chứng Churg-Strauss
@vi
Siondróm Churg-Strauss
@ga
Syndrom Churg-Straussové
@cs
Syndroom van Churg-Strauss
@nl
Síndrome de Churg-Strauss
@es
Síndrome de Churg-Strauss
@gl
type
label
Churg-Strauss syndrome
@en
Churg-Strauss-Syndrom
@de
Churg–Strauss syndrom
@sv
Eosinofil granulomatose med polyangiit
@nb
Hội chứng Churg-Strauss
@vi
Siondróm Churg-Strauss
@ga
Syndrom Churg-Straussové
@cs
Syndroom van Churg-Strauss
@nl
Síndrome de Churg-Strauss
@es
Síndrome de Churg-Strauss
@gl
altLabel
Alerģisks granulomatozs angiīts
@lv
Alerģiskā granulomatoze
@lv
Allergic Angiitides
@en
Allergic Angiitides, Granulomatous
@en
Allergic Angiitis and Granulomatosis
@en
Allergic Angiitis
@en
Allergic Angiitis, Granulomatous
@en
Allergic Granulomatoses
@en
Allergic Granulomatosis
@en
Allergic Granulomatous Angiitides
@en
prefLabel
Churg-Strauss syndrome
@en
Churg-Strauss-Syndrom
@de
Churg–Strauss syndrom
@sv
Eosinofil granulomatose med polyangiit
@nb
Hội chứng Churg-Strauss
@vi
Siondróm Churg-Strauss
@ga
Syndrom Churg-Straussové
@cs
Syndroom van Churg-Strauss
@nl
Síndrome de Churg-Strauss
@es
Síndrome de Churg-Strauss
@gl
P279
P2888
P672
P244
P486
P646
P1325
P1461
churg-strauss-syndrome
P1748
P18
P1995
P2176
P244
sh96009247
P279
P2892
P3720
P373
Churg-Strauss syndrome